Autres langues Merck & Co., Inc.

Actions

MRK

US58933Y1055

Produits pharmaceutiques

Marché Fermé - Nyse Autres places de cotation 22:00:31 11/05/2026			Varia. 5j.	Varia. 1 janv.
111,28 ^USD	-0,09 %		-1,62 %	+5,72 %

11/05	Sony rachète le catalogue de Recognition, géant des droits musicaux	AW
11/05	Erasca s'associe à Merck pour l'étude AURORAS-1 sur le cancer	MT

Autres langues

11/05	Erasca Teams With Merck on AURORAS-1 Cancer Study
11/05	El éxito fiscal de Irlanda frente al riesgo de dependencia
08/05	Merck : Statement on Daiichi Sankyo Update to Manufacturing and Supply Plan - Merck.com
07/05	Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate
07/05	The Rally Spreads
07/05	Nykode Therapeutics Doses First Patient in Abili-T Phase II Randomized Trial evaluating Abi-suva in HPV16-Positive, PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer Patients
05/05	Merck Completes Terns Pharmaceuticals Acquisition
05/05	Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
04/05	Global pharma companies that have publicly announced Trump drug pricing agreements
01/05	Big Pharma M&A set for mega year as patent expiries drive deal urgency
01/05	Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales
30/04	S&P 500, Nasdaq on course for best month since 2020 despite Middle East risks
30/04	MÄRKTE USA/Sehr fest - Zwischen Tech-Zahlen und Ölpreis-Entwicklung
30/04	Wall St set to climb at open as earnings optimism overshadows oil woes
30/04	Wall St futures climb as investors balance earnings optimism against oil woes
30/04	Merck beats quarterly sales expectations as Keytruda fuels growth
30/04	MÄRKTE USA/Fester - Zwischen Tech-Zahlen und Ölpreis-Entwicklung
30/04	Merck Q1 adjusted loss per share $1.28 versus IBES estimate $-1.51
30/04	S&P 500, Nasdaq on course for best month since 2020 despite Middle East risks
30/04	Merck posts quarterly loss due to Cidara charge, sales rise 5%
30/04	Borsa Usa, S&P 500 e Nasdaq verso miglior mese da 2020, malgrado rischi Medio Oriente
30/04	El S&P 500 y el Nasdaq anotan su mejor mes desde 2020 pese a los riesgos por la guerra
30/04	Merck 1Q Sales Rise on Continued Keytruda Growth -- Update
30/04	Wall Street - keine Entspannung bei den Daten
30/04	MÄRKTE USA/Uneinheitlich - Alphabet sehr fest - Meta-Kurs stürzt ab